SCHEMBL29678394

SCHEMBL29678394

CC(=O)N1CCN(c2ncccc2C#N)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.65
▸ ALDH1A1 P00352 2/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ PANK3 Q9H999 1/20 0.61
▸ RECQL P46063 1/20 0.61
▸ MAPT P10636 1/20 0.57
▸ CA12 O43570 1/20 0.57
▸ CA1 P00915 1/20 0.57
▸ CA2 P00918 1/20 0.57
▸ CA9 Q16790 1/20 0.57
▸ HSD11B1 P28845 2/20 0.56
▸ HDAC2 Q92769 2/20 0.55
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ DRD2 P14416 2/20 0.52
▸ HTR2A P28223 1/20 0.52
▸ GRM1 Q13255 1/20 0.51
▸ PARP1 P09874 1/20 0.50
▸ PARP2 Q9UGN5 1/20 0.50
▸ PARP3 Q9Y6F1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862949 1.00 KDM4E (0.65) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL5901321 0.87 KDM4E (0.68) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL8235906 0.85 KDM4E (0.69) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL14566007 0.84 KDM4E (0.62) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL3334496 0.83 KDM4E (0.69) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL3334438 0.83 KDM4E (0.69) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL8167178 0.83 KDM4E (0.69) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL3538823 0.82 KDM4E (0.59) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL3336022 0.82 KDM4E (0.65) KDM4EALDH1A1TDP1PANK3RECQL
SCHEMBL2076147 0.81 ALDH1A1 (0.60) KDM4EALDH1A1TDP1PANK3RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003999-A1 1-(6-(METHOXY)PYRIDAZIN-3-YL)CYCLOPROPANE-1-CARBOXAMIDE DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR THE TREATMENT OF INFLAMMATORY AIRWAY DISEASES Boehringer Ingelheim International GmbH (DE) 2022-06-01 — — EP disclosed
Send feedback